Sagimet Biosciences Inc. (SGMT) financial statements and ratios from SEC XBRL: revenue $2.00M (TTM), net margin -1393.8%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.00M |
| Net Margin | -1393.8% |
| Price / Book | 2.13 |
| Sector P/E (Healthcare) | 21.7 |
SGMT overview · SGMT earnings · SGMT KPIs · SGMT investor relations · SGMT ownership · SGMT peers · SGMT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.